13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05062083 (ClinicalTrials.gov) | June 7, 2022 | 29/9/2021 | PET Imaging of Cyclooxygenase-2 in Multiple Sclerosis | PET Imaging of Cyclooxygenases in Multiple Sclerosis | Multiple Sclerosis | Drug: 11C-MCI;Drug: 11C-PS13 | National Institute of Mental Health (NIMH) | University of Maryland | Recruiting | 18 Years | 99 Years | All | 16 | Phase 2 | United States |